文献速递传染病防控与疫情报告免疫规划

商业综合征候群聚合酶链反应检测面板纳入麻疹检测的影响——美国,2022年5月至2023年4月

Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-03-28

商业综合征候群PCR面板可检出麻疹疫苗病毒,导致假阳性报告。2022年5月至2023年4月,1548份面板中17份(1.1%)麻疹病毒阳性,14名有接种信息者均在采样前中位12天接种MMR疫苗且无麻疹感染危险因素,所有阳性均归因于疫苗病毒检测。

要点

  • 综合征候群PCR面板可检出MMR疫苗中的减毒麻疹病毒,约5%的人接种后7-10天出现皮疹。
  • 1548份面板中17份(1.1%)麻疹病毒阳性,14名有信息者均在采样前中位12天接种MMR疫苗且无感染危险因素。
  • 任何综合征候群PCR检出的麻疹病毒应立即报告公共卫生机构,结合接种史和危险因素评估。

核心结论

  • 所有阳性PCR结果均归因于麻疹疫苗病毒检测,需提高医务人员对接种后PCR可能检出麻疹病毒的认识。
  • 任何综合征候群PCR检测检出麻疹病毒应立即报告公共卫生机构,由其利用麻疹疫苗接种史和危险因素评估确定适当公共卫生应对。
  • 若某人近期接种MMR疫苗且无麻疹感染危险因素,额外公共卫生应对很可能不必要。

研究设计与样本

  • 田纳西州卫生部于2022年9月至2023年1月收到两份经综合征候群PCR面板检出麻疹的报告,涉及1岁和6岁儿童,均在常规MMR接种后11-13天因皮疹评估,无已知麻疹危险因素。
  • 田纳西州公共卫生应对确定两份PCR面板均检出麻疹疫苗病毒后,六个州卫生部门合作评估美国麻疹PCR面板阳性结果的频率和特征。
  • 从一家商业实验室回顾性收集2022年5月至2023年4月综合征候群多重PCR面板检测麻疹的信息。

主要发现

  • 2022年5月至2023年4月,1548份综合征候群PCR面板中17份(1.1%)麻疹病毒阳性。
  • 14名有接种和病例调查信息者均在采样前中位12天接种MMR疫苗,且无已知麻疹感染危险因素。
  • 所有阳性PCR结果均归因于麻疹疫苗病毒检测。

临床怎么用

  • 任何综合征候群PCR检测检出麻疹病毒应立即报告公共卫生机构。
  • 公共卫生机构可利用麻疹疫苗接种史和危险因素评估确定适当公共卫生应对。
  • 若某人近期接种MMR疫苗且无麻疹感染危险因素,额外公共卫生应对很可能不必要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Syndromic polymerase chain reaction (PCR) panels are used to test for pathogens that can cause rash illnesses, including measles. Rash illnesses have infectious and noninfectious causes, and approximately 5% of persons experience a rash 7-10 days after receipt of a measles, mumps, and rubella (MMR) vaccine. MMR vaccine includes live attenuated measles virus, which is detectable by PCR tests. No evidence exists of person-to-person transmission of measles vaccine virus, and illness does not typically result among immunocompetent persons. During September 2022-January 2023, the Tennessee Department of Health received two reports of measles detected by syndromic PCR panels. Both reports involved children (aged 1 and 6 years) without known risk factors for measles, who were evaluated for rash that occurred 11-13 days after routine MMR vaccination. After public health responses in Tennessee determined that both PCR panels had detected measles vaccine virus, six state health departments collaborated to assess the frequency and characteristics of persons receiving a positive measles PCR panel test result in the United States. Information was retrospectively collected from a commercial laboratory testing for measles in syndromic multiplex PCR panels. During May 2022-April 2023, among 1,548 syndromic PCR panels, 17 (1.1%) returned positive test results for measles virus. Among 14 persons who received a positive test result and for whom vaccination and case investigation information were available, all had received MMR vaccine a median of 12 days before specimen collection, and none had known risk factors for acquiring measles. All positive PCR results were attributed to detection of measles vaccine virus. Increased awareness among health care providers about potential measles detection by PCR after vaccination is needed. Any detection of measles virus by syndromic PCR testing should be immediately reported to public health agencies, which can use measles vaccination history and assessment of risk factors to determine the appropriate public health response. If a person recently received MMR vaccine and has no risk factors for acquiring measles, additional public health response is likely unnecessary.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Thomas CM, Hartley A, Schmitz A, et al. Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38547036. doi:10.15585/mmwr.mm7312a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。